These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28692215)

  • 1. [Faecal calprotectin : a useful tool for the primary care physician ?].
    D'angelo F; Perrier A
    Rev Med Suisse; 2016 Oct; 12(535):1752-1756. PubMed ID: 28692215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
    Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
    J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study.
    Kok L; Elias SG; Witteman BJ; Goedhard JG; Muris JW; Moons KG; de Wit NJ
    Clin Chem; 2012 Jun; 58(6):989-98. PubMed ID: 22407858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
    Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of fecal calprotectin determination in pediatric intestinal diseases.
    Rosso C; Caviglia GP; Pellicano R
    Minerva Pediatr; 2016 Dec; 68(6):478-486. PubMed ID: 27668453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
    Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
    Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S; Shajib MS; Reinisch W; Khan WI
    J Gastroenterol; 2016 May; 51(5):434-46. PubMed ID: 26897740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn's disease.
    Hale MF; Drew K; McAlindon ME; Sidhu R
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1145-50. PubMed ID: 27384306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calprotectin in Daily Practice: Where Do We Stand in 2017?
    D'Angelo F; Felley C; Frossard JL
    Digestion; 2017; 95(4):293-301. PubMed ID: 28511188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
    Saha A; Tighe MP; Batra A
    Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease.
    Zhang W; Wong CH; Chavannes M; Mohammadi T; Rosenfeld G
    BMJ Open; 2019 Apr; 9(4):e027043. PubMed ID: 30987989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ
    J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
    Zippi M; Al Ansari N; Siliquini F; Severi C; Kagarmanova A; Maffia C; Parlanti S; Garbarino V; Maccioni F
    Clin Ter; 2010; 161(2):e53-6. PubMed ID: 20499020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the faecal calprotectin test?
    Drug Ther Bull; 2014 Sep; 52(9):102-4. PubMed ID: 25213590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
    Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
    Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.